Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives

被引：82

作者：

Ganesh, Balasubramanian ^{[1
]}

Rajakumar, Thangarasu ^{[1
]}

Malathi, Mathiyazhakan ^{[1
]}

Manikandan, Natesan ^{[1
]}

Nagaraj, Jaganathasamy ^{[1
]}

Santhakumar, Aridoss ^{[1
]}

Elangovan, Arumugam ^{[1
]}

Malik, Yashpal Singh ^{[2
]}

机构：

[1] ICMR Natl Inst Epidemiol ICMR NIE, TNHB, R-127,Second Main Rd, Chennai 600077, Tamil Nadu, India

[2] Indian Vet Res Inst IVRI, Bareilly 243122, Uttar Pradesh, India

来源：

CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH | 2021年 / 10卷

关键词：

COVID-19; SARS-CoV-2; SARS-CoV; MERS-CoV; Epidemiology; Pathobiology; EAST RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS; FUNCTIONAL RECEPTOR; SPIKE; TRANSMISSION; INFECTION; VACCINES; LESSONS; COV; THERAPY;

D O I：

10.1016/j.cegh.2020.100694

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative etiology of 'Corona Virus Disease-2019' (COVID-19); formerly referred as 'novel-Coronavirus-2019'. It was originated in Wuhan city, Hubei province, China in early December 2019. The World Health Organization (WHO) declared it as 'Public Health Emergency of International Concern' due to their rapid transmission and causing public and health-carerelated casualties worldwide. This review provides an updated overview of COVID-19 (SARS-CoV-2), in comparison with the etiologies of the same group viz. SARS and MERS and also its future perspectives for planning appropriate strategies for prevention, control and treatment modalities to avert similar catastrophe in near future.

引用

页数：10

共 92 条

[1]

Agriculture Fisheries and Conservation Department (AFCD), DET LOW LEV COVID 19

[2] Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description [J].

Al-Abdallat, Mohammad Mousa ;

Payne, Daniel C. ;

Alqasrawi, Sultan ;

Rha, Brian ;

Tohme, Rania A. ;

Abedi, Glen R. ;

Al Nsour, Mohannad ;

Iblan, Ibrahim ;

Jarour, Najwa ;

Farag, Noha H. ;

Haddadin, Aktham ;

Al-Sanouri, Tarek ;

Tamin, Azaibi ;

Harcourt, Jennifer L. ;

Kuhar, David T. ;

Swerdlow, David L. ;

Erdman, Dean D. ;

Pallansch, Mark A. ;

Haynes, Lia M. ;

Gerber, Susan I. .

CLINICAL INFECTIOUS DISEASES, 2014, 59 (09) :1225-1233

[3] COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection [J].

Al-Samkari, Hanny ;

Leaf, Rebecca S. Karp ;

Dzik, Walter H. ;

Carlson, Jonathan C. T. ;

Fogerty, Annemarie E. ;

Waheed, Anem ;

Goodarzi, Katayoon ;

Bendapudi, Pavan K. ;

Bornikova, Larissa ;

Gupta, Shruti ;

Leaf, David E. ;

Kuter, David J. ;

Rosovsky, Rachel P. .

BLOOD, 2020, 136 (04) :489-500

[4] Chilblains in children in the setting of COVID-19 pandemic [J].

Andina, David ;

Noguera-Morel, Lucero ;

Bascuas-Arribas, Marta ;

Gaitero-Tristan, Jara ;

Antonio Alonso-Cadenas, Jose ;

Escalada-Pellitero, Silvia ;

Hernandez-Martin, Angela ;

de la Torre-Espi, Mercedes ;

Colmenero, Isabel ;

Torrelo, Antonio .

PEDIATRIC DERMATOLOGY, 2020, 37 (03) :406-411

[5]

[Anonymous], 2003, Wkly Epidemiol Rec, V78, P89

[6]

[Anonymous], 2018, MIDDLE E RESP SYNDRO

[7] Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol [J].

Arabi, Yaseen ;

Balkhy, Hanan ;

Hajeer, Ali H. ;

Bouchama, Abderrezak ;

Hayden, Frederick G. ;

Al-Omari, Awad ;

Al-Hameed, Fahad M. ;

Taha, Yusri ;

Shindo, Nahoko ;

Whitehead, John ;

Merson, Laura ;

AlJohani, Sameera ;

Al-Khairy, Khalid ;

Carson, Gail ;

Luke, Thomas C. ;

Hensley, Lisa ;

Al-Dawood, Abdulaziz ;

Al-Qahtani, Saad ;

Modjarrad, Kayvon ;

Sadat, Musharaf ;

Rohde, Gernot ;

Leport, Catherine ;

Fowler, Robert .

SPRINGERPLUS, 2015, 4 :1-8

[8] Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial [J].

Arabi, Yaseen M. ;

Asiri, Ayed Y. ;

Assiri, Abdullah M. ;

Aziz Jokhdar, Hani A. ;

Alothman, Adel ;

Balkhy, Hanan H. ;

AlJohani, Sameera ;

Al Harbi, Shmeylan ;

Kojan, Suleiman ;

Al Jeraisy, Majed ;

Deeb, Ahmad M. ;

Memish, Ziad A. ;

Ghazal, Sameeh ;

Al Faraj, Sarah ;

Al-Hameed, Fahad ;

AlSaedi, Asim ;

Mandourah, Yasser ;

Al Mekhlafi, Ghaleb A. ;

Sherbeeni, Nisreen Murad ;

Elzein, Fatehi Elnour ;

Almotairi, Abdullah ;

Al Bshabshe, Ali ;

Kharaba, Ayman ;

Jose, Jesna ;

Al Harthy, Abdulrahman ;

Al Sulaiman, Mohammed ;

Mady, Ahmed ;

Fowler, Robert A. ;

Hayden, Frederick G. ;

Al-Dawood, Abdulaziz ;

Abdelzaher, Mohamed ;

Bajhmom, Wail ;

Hussein, Mohamed A. .

TRIALS, 2020, 21 (01)

[9] The multifunctional or moonlighting protein CD26/DPPIV [J].

Boonacker, E ;

Van Noorden, CJF .

EUROPEAN JOURNAL OF CELL BIOLOGY, 2003, 82 (02) :53-73

[10] Clusters of coronavirus cases put scientists on alert [J].

Butler, Declan .

NATURE, 2012, 492 (7428) :166-167

← 1 2 3 4 5 6 7 8 9 10 →